GLIMITERIS TRIO 0.2 (Voglibose 0.2 mg, Glimepiride 3 mg & Metformin Hydrochloride 500 mg ): explore......

 GLIMITERIS TRIO 0.2 

Voglibose 0.2 mg, Glimepiride 3 mg & Metformin Hydrochloride 500 mg

GLIMITERIS TRIO 0.2 is a combination medication used to manage type 2 diabetes mellitus. It contains Voglibose 0.2 mg, Glimepiride 3 mg, and Metformin Hydrochloride 500 mg. This potent trio works synergistically to control blood sugar levels, providing an effective treatment option for patients who struggle to manage their diabetes with monotherapy or dual therapy. Understanding how each component works and their collective benefits is essential for maximizing treatment outcomes.

What is GLIMITERIS TRIO 0.2?

GLIMITERIS TRIO 0.2 is an oral antidiabetic medication that combines three active ingredients:

1. Voglibose 0.2 mg: An alpha-glucosidase inhibitor that delays glucose absorption in the intestines.
2. Glimepiride 3 mg: A sulfonylurea that stimulates insulin secretion from the pancreas.
3. Metformin Hydrochloride 500 mg: A biguanide that reduces hepatic glucose production and enhances insulin sensitivity.

Uses

GLIMITERIS TRIO 0.2 is primarily used for:

• Managing Type 2 Diabetes: It helps in controlling high blood sugar levels, thereby preventing complications such as kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems.

How It Works

• Voglibose:  This inhibition slows down the breakdown and absorption of carbohydrates, leading to a gradual rise in blood sugar levels post-meal. It effectively reduces postprandial hyperglycemia, which is crucial for managing diabetes.

• Glimepiride: It lowers blood sugar by causing the pancreas to produce insulin and helping the body use insulin efficiently. Glimepiride’s action helps in reducing fasting blood sugar levels and maintaining overall blood glucose control.

• Metformin Hydrochloride: Metformin works by decreasing hepatic glucose production, decreasing intestinal absorption of glucose, and improving insulin sensitivity by increasing peripheral glucose uptake and utilization. It does not cause insulin release from the pancreas, thus it generally does not lead to hypoglycemia.

Dosage

• Standard Dose: The typical dose of GLIMITERIS TRIO 0.2 is one tablet taken orally once a day, usually with the first main meal of the day to minimize gastrointestinal side effects and to enhance its efficacy.

• Dose Adjustments: The dosage may be adjusted based on the patient's current blood glucose levels, response to treatment, and the presence of any side effects. It is essential to follow the healthcare provider’s instructions closely to achieve optimal blood sugar control.

Side Effects

As with any medication, GLIMITERIS TRIO 0.2 may cause side effects. Common side effects include:

• Gastrointestinal Issues: Diarrhea, nausea, vomiting, abdominal discomfort, and bloating are common, especially during the initial weeks of treatment. These symptoms often diminish over time.

• Hypoglycemia: Glimepiride can cause low blood sugar levels, particularly if meals are skipped or after intense physical activity. Symptoms of hypoglycemia include sweating, dizziness, shaking, hunger, and confusion.

• Allergic Reactions: Although rare, some individuals may experience allergic reactions such as rash, itching, or swelling, especially around the face and throat. 

Price

The cost of GLIMITERIS TRIO 0.2 can vary based on the pharmacy, location, and availability of the medication. In India, the price range is generally between INR 100 to INR 300 per strip of 10 tablets. It is advisable to check with local pharmacies or online platforms for the most current prices and any available discounts.

Conclusion

GLIMITERIS TRIO 0.2, a combination of Voglibose 0.2 mg, Glimepiride 3 mg, and Metformin Hydrochloride 500 mg, offers a comprehensive approach to managing type 2 diabetes. By targeting different mechanisms of action, it effectively controls blood sugar levels and reduces the risk of diabetes-related complications. While it is generally well-tolerated, patients should be aware of potential side effects and adhere strictly to the prescribed dosage. Regular monitoring of blood glucose levels, a balanced diet, and consistent physical activity are essential components of a successful diabetes management plan alongside GLIMITERIS TRIO 0.2. Always consult with a healthcare provider to determine the best treatment strategy for individual needs. Steris Healthcare Pvt Ltd, operating as Sterispharma since its founding by expert professionals in the pharmaceutical industry in February 2018, is based in Navi Mumbai. The company is certified by WHO, GMP, and ISO, emphasizing its commitment to quality and safety. Sterispharma focuses on providing high-quality drugs at affordable prices throughout India, adhering strictly to WHO guidelines. Offering the convenience of an online pharmacy, customers can easily purchase medicines with home delivery options available. Sterispharma's mission is to supply a broad range of healthcare products to meet the diverse needs of the medical community. From advanced treatments and medications for rare conditions to essential health necessities, Sterispharma aims to serve the extensive demands of the healthcare industry. You can order medicines from Sterispharma through their websites, sterisonline and sterispharma. Their extensive product lineup includes treatments for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology.

For further information 

Email: info@sterispharma.com /  contact@sterispharma.com

Call/WhatsApp:  7877551268, 7849827488 

BUY NOW